Form 4: Nuvalent Director Joseph Pearlberg Reports Acquisition of RSUs and Stock Options

Nuvalent, Inc. Director Joseph Pearlberg reported the acquisition of 2,647 restricted stock units and 4,147 stock options, which vest based on continued service, as part of his compensation.

Summary

• Joseph Pearlberg, a Director of Nuvalent, Inc. (NUVL), reported new equity awards on June 18, 2025.
• He acquired 2,647 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) at an acquisition price of $0.00.
• He also acquired 4,147 stock options with an exercise price of $75.53, also at an acquisition price of $0.00.
• Both the RSUs and stock options are set to vest in full on the earlier of June 18, 2026, or the date of Nuvalent, Inc.'s next annual meeting of stockholders, contingent on his continued service to the company.
• The stock options have an expiration date of June 18, 2035.
• Following these transactions, Mr. Pearlberg beneficially owns 5,146 shares of Class A Common Stock and 4,147 stock options.
• Mr. Pearlberg, an employee of Deerfield Management Company, L.P., disclaims pecuniary interest in these securities, holding them for the benefit and at the direction of Deerfield Management Company, L.P.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation for a director, aligning their interests with the company's long-term performance. The awards are subject to vesting, incentivizing continued service. The disclaimer of pecuniary interest by the director, holding for Deerfield Management, is a neutral aspect reflecting a common governance structure.

Positives

• The grant of equity awards (RSUs and stock options) to a director aligns his interests with those of the company's shareholders, incentivizing long-term performance.
• The awards are subject to continued service, which encourages the director's ongoing commitment to Nuvalent, Inc.

Negatives

• The awards do not provide immediate cash compensation to the director, as they are subject to future vesting.
• The director disclaims pecuniary interest, holding the securities for Deerfield Management Company, L.P., which may imply less direct personal financial incentive for the individual director compared to direct personal ownership.

Risks

• The vesting of the RSUs and stock options is contingent upon Joseph Pearlberg's continued service to Nuvalent, Inc., meaning the awards could be forfeited if his service ceases before the vesting dates.
• The value realized from the stock options is dependent on Nuvalent, Inc.'s stock price exceeding the exercise price of $75.53 in the future.

Future Outlook

The vesting schedule for the RSUs and stock options indicates a future commitment from the director, with full vesting expected by June 18, 2026, or the next annual meeting, subject to continued service. The stock options have a long-term expiration date of June 18, 2035, suggesting a long-term incentive for the director.

Management Comments

• "The Reporting Person, an employee of Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P."

Industry Context

This Form 4 filing reports routine insider equity compensation, a common practice across industries, including the biotech/pharma sector (implied by Nuvalent's ticker NUVL). Such compensation aims to align management interests with long-term company performance. The involvement of Deerfield Management Company, L.P. suggests a representative of a significant institutional investor on the board, which is typical for growth-stage companies.

Comparison to Industry Standards

• Granting equity awards like RSUs and stock options to directors is a standard practice across various industries, including biotech, to incentivize performance and retention.
• The vesting schedule (earlier of two dates, subject to continued service) is a typical mechanism for such compensation awards.
• The disclaimer of pecuniary interest by the director, holding securities for an investment firm (Deerfield Management), is common when a board member serves as a representative of a significant institutional investor, reflecting a standard governance structure in companies with venture capital backing.

Corporate Governance

Related Party Transactions

• The reporting person, Joseph Pearlberg, is an employee of Deerfield Management Company, L.P., and holds the reported securities for their benefit and at their direction. This indicates a relationship where Deerfield Management Company, L.P. likely has a significant investment or influence in Nuvalent, Inc., and Mr. Pearlberg serves as their representative on the board.

Stakeholder Impact

• Shareholders: The grant of equity awards to a director aims to align their interests with shareholders, potentially leading to better long-term performance. The awards are non-dilutive until exercised/vested.
• Employees: No direct impact on employees is mentioned, but the general practice of equity compensation can be seen as a positive for talent retention within the company.

Next Steps

• Continued service of Joseph Pearlberg to Nuvalent, Inc. for the vesting of awards.
• Nuvalent, Inc.'s next annual meeting of stockholders, which serves as a potential vesting trigger.
• Potential exercise of stock options by June 18, 2035, if the stock price is favorable.

Key Dates

Recommendation

Keywords

Nuvalent, NUVL, SEC Form 4, insider transaction, beneficial ownership, stock options, restricted stock units, RSU, director compensation, equity awards, Deerfield Management Company